|
Volumn 91, Issue 5, 2015, Pages 412-417
|
Ovarian cysts: Presence and persistence with use of a 13.5 mg levonorgestrel-releasing intrauterine system
|
Author keywords
Intrauterine contraception; Intrauterine device; Intrauterine system; Levonorgestrel; LNG IUS; Ovarian cyst
|
Indexed keywords
LEVONORGESTREL;
CONTRACEPTIVE AGENT;
ADULT;
ARTICLE;
CLINICAL ASSESSMENT;
CLINICAL EVALUATION;
COMPARATIVE STUDY;
CONTROLLED STUDY;
DEVICE SAFETY;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
FOLLOW UP;
GYNECOLOGICAL EXAMINATION;
HUMAN;
IMAGE ANALYSIS;
LEVONORGESTREL RELEASING INTRAUTERINE SYSTEM;
LOW DRUG DOSE;
MAJOR CLINICAL STUDY;
MENSTRUAL CYCLE;
MULTICENTER STUDY;
OVARY CYST;
PELVIC EXAMINATION;
PHASE 3 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
SCREENING TEST;
TRANSVAGINAL ECHOGRAPHY;
VAGINA CONTRACEPTION;
ADOLESCENT;
ADVERSE EFFECTS;
CLINICAL TRIAL;
CONTRACEPTION;
ECHOGRAPHY;
INTRAUTERINE CONTRACEPTIVE DEVICE;
NORMAL HUMAN;
OVARIAN CYSTS;
YOUNG ADULT;
ADOLESCENT;
ADULT;
CONTRACEPTION;
CONTRACEPTIVE AGENTS, FEMALE;
FEMALE;
FOLLOW-UP STUDIES;
GYNECOLOGICAL EXAMINATION;
HEALTHY VOLUNTEERS;
HUMANS;
INTRAUTERINE DEVICES, MEDICATED;
LEVONORGESTREL;
OVARIAN CYSTS;
YOUNG ADULT;
|
EID: 84928762460
PISSN: 00107824
EISSN: 18790518
Source Type: Journal
DOI: 10.1016/j.contraception.2015.01.021 Document Type: Article |
Times cited : (23)
|
References (8)
|